688089.SH
Cabio Biotech (Wuhan) Co., Ltd.
SSE · Healthcare · Biotechnology · CN
CNY 7.56
+0.67%Forward multiples
Based on analyst estimates
- P/E forward
- 43.92x
- P/E 2026E
- 7.15x
- P/E 2027E
- 6.12x
- P/E 2028E
- —
- P/S forward
- 2.91x
Trailing multiples
Trailing twelve months
- P/E TTM
- 8.75x
- PEG TTM
- 0.83x
- Price / book
- 0.85x
- Price / sales
- 3.37x
- Price / cash flow
- 6.28x
Enterprise value
- Enterprise value
- CNY 1.4B
- EV / sales
- 3.34x
- EV / EBITDA
- 6.57x
- EV / EBIT
- 24.93x
- Market cap
- CNY 1.3B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Mar 1, 2026